Hydrophobic Oligonucleotide Loading for Scalable Exosome Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for loading nucleic acid cargo into exosomes are inefficient and non-scalable, resulting in low loading efficiency and limited commercial potential of exosomes as delivery vehicles.
Innovation Solution
The introduction of hydrophobic modifications to oligonucleotides facilitates efficient loading of exosomes by incubating the modified oligonucleotides with exosomes, eliminating the need for electroporation or cationic lipid reagents, and allowing rapid production of oligonucleotide-loaded exosomes in therapeutic quantities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods (electroporation, cationic lipid transfection, ultracentrifugation) are used to load oligonucleotides into exosomes, then the loading process can be performed, but the loading efficiency is very low (only a small fraction of added oligonucleotide molecules are transferred to exosomes)
Solution Approach 1:
The patent modifies the chemical parameters of the oligonucleotide by introducing hydrophobic modifications (such as cholesterol conjugation, 2'-O-methyl modifications, phosphorothioate backbone modifications). These parameter changes enable the oligonucleotide to interact with the lipid bilayer of exosomes, dramatically improving loading efficiency from less than 0.1% to over 80% without requiring complex external loading devices
Solution Approach 2:
The patent creates a composite structure by conjugating hydrophobic moieties (such as cholesterol molecules) to the hydrophilic oligonucleotide backbone. This composite material possesses both the water-solubility needed for biological compatibility and the membrane-interaction capability of hydrophobic molecules, enabling efficient exosomal loading through simple incubation
2Productivity
If conventional loading methods are used, then the process can be performed, but the method is non-scalable and cannot produce therapeutic quantities efficiently
Solution Approach 1:
The hydrophobically modified oligonucleotide automatically incorporates into exosomes through passive diffusion into the lipid bilayer during simple incubation, without requiring external energy input (electroporation), complex reagents (cationic lipids), or sophisticated equipment (ultracentrifugation). This self-loading mechanism enables scalable production by eliminating process bottlenecks
Solution Approach 2:
The patent extracts and eliminates the complex loading equipment and reagents from the process. By incorporating hydrophobic modifications directly into the oligonucleotide, the patent removes the need for electroporation devices, cationic lipid transfection reagents, and ultracentrifugation equipment, simplifying the process to basic incubation conditions that are easily scalable
3Manufacturing precision
If hydrophobic modifications are introduced to oligonucleotides, then loading efficiency increases dramatically (at least 80% of exosomes loaded with up to 3000 oligonucleotides per exosome), but the oligonucleotide structure becomes more complex
Solution Approach 1:
Rather than modifying the entire oligonucleotide structure extensively, the patent applies hydrophobic modifications at specific local positions - typically conjugating a single hydrophobic moiety (such as cholesterol) to one end of the oligonucleotide or modifying a small fraction of nucleotides. This localized modification provides sufficient membrane interaction capability while preserving the overall simplicity of the oligonucleotide structure and its therapeutic function
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high loading efficiency, with at least 80% of exosomes loaded with oligonucleotides and up to 3000 oligonucleotides per exosome, enabling scalable production for therapeutic applications.
Implementation Method 1
introduction of a hydrophobic modification into an oligonucleotide facilitates exosomal loading
Data Source
AI summary
In one aspect, the invention relates to a method of loading exosomes with oligonucleotide cargo, by incubating an oligonucleotide comprising one or more hydrophobic modifications with a population of exosomes for a period of time sufficient to allow loading of the exosomes with the oligonucleotide. Exosomes loaded with hydrophobically modified oligonucleotide cargo, and uses thereof, are also provided.